200 related articles for article (PubMed ID: 38265528)
1. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
Fernandes R; Sabino R; Cunha C; Cornely OA; Carvalho A; Salmanton-García J;
Mycopathologia; 2024 Jan; 189(1):15. PubMed ID: 38265528
[TBL] [Abstract][Full Text] [Related]
2. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
Vena A; Bassetti M; Mezzogori L; Marchesi F; Hoenigl M; Giacobbe DR; Corcione S; Bartoletti M; Stemler J; Pagano L; Cornely OA; Salmanton-García J
Infection; 2024 Feb; 52(1):197-208. PubMed ID: 37656348
[TBL] [Abstract][Full Text] [Related]
3. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.
Salmanton-García J; Hoenigl M; Gangneux JP; Segal E; Alastruey-Izquierdo A; Arikan Akdagli S; Lagrou K; Özenci V; Vena A; Cornely OA
Lancet Microbe; 2023 Jan; 4(1):e47-e56. PubMed ID: 36463916
[TBL] [Abstract][Full Text] [Related]
4. The Argentinian landscape of mycological diagnostic capacity and treatment accessibility.
Riera F; Caeiro JP; Cornely OA; Salmanton-García J;
Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37312404
[TBL] [Abstract][Full Text] [Related]
5. The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).
Salmanton-García J; Au WY; Hoenigl M; Chai LYA; Badali H; Basher A; Brockhoff RA; Chen SC; Chindamporn A; Chowdhary A; Heath CH; Jabeen K; Lee J; Matar M; Taj-Aldeen SJ; Tan BH; Uno K; Wahyuningsih R; Zhu L; Chakrabarti A; Cornely OA
Int J Antimicrob Agents; 2023 Mar; 61(3):106718. PubMed ID: 36640851
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
Kovács R; Majoros L; Stemler J; Cornely OA; Salmanton-García J
Ther Adv Infect Dis; 2023; 10():20499361231219315. PubMed ID: 38116297
[TBL] [Abstract][Full Text] [Related]
7. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
[TBL] [Abstract][Full Text] [Related]
8. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.
Tan BH; Chakrabarti A; Patel A; Chua MMM; Sun PL; Liu Z; Rotjanapan P; Li R; Wahyuningsih R; Chayakulkeeree M; Chen YC;
Int J Infect Dis; 2020 Jun; 95():471-480. PubMed ID: 31945491
[TBL] [Abstract][Full Text] [Related]
9. The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey.
Driemeyer C; Falci DR; Oladele RO; Bongomin F; Ocansey BK; Govender NP; Hoenigl M; Gangneux JP; Lass-Flörl C; Cornely OA; Alanio A; Guinea J; Morrissey CO; Rautemaa-Richardson R; Chakrabarti A; Meis JF; Bruns C; Stemler J; Pasqualotto AC
Lancet Microbe; 2022 Jun; 3(6):e464-e470. PubMed ID: 35659908
[TBL] [Abstract][Full Text] [Related]
10. Antifungal use in children with acute leukaemia: state of current evidence and directions for future research.
Yeoh DK; Haeusler GM; McMullan BJ; Butters C; Bryant PA; Clark JE; Cooper CM; Gwee A; Kotecha RS; Lai T; Slavin MA; Thursky KA; Blyth CC
J Antimicrob Chemother; 2022 May; 77(6):1508-1524. PubMed ID: 35301533
[TBL] [Abstract][Full Text] [Related]
11. The current state of Clinical Mycology in Eastern and South-Eastern Europe.
Driemeyer C; Falci DR; Hoenigl M; Cornely OA; Chakrabarti A; Gangneux JP; Segal E; Jürna-Ellam M; Matos T; Meis JF; Perfect JR; Arsenijevic VA; Mares M; Serban DE; Pasqualotto AC
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35195256
[TBL] [Abstract][Full Text] [Related]
12. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
Gómez-López A
Clin Microbiol Infect; 2020 Nov; 26(11):1481-1487. PubMed ID: 32535150
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
17. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients.
John J; Loo A; Mazur S; Walsh TJ
Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):881-895. PubMed ID: 31550939
[No Abstract] [Full Text] [Related]
19. Recent advances in the treatment of life-threatening, invasive fungal infections.
Drew RH; Townsend ML; Pound MW; Johnson SW; Perfect JR
Expert Opin Pharmacother; 2013 Dec; 14(17):2361-74. PubMed ID: 24050675
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Analysis of 164 Children of Blood Disease Complicated with Invasive Fungal Disease].
Liao XY; Qiu KY; Wu RH; Guo SY; Wang J; Huang K; Xu HG; Li Y; Fang JP; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1672-1677. PubMed ID: 31607330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
